We report a case of itchy papulovesicular rash consistent with varicella-zoster virus reactivation after Pfizer-BioNTech vaccine second dose administration. While there have been cases of varicella-zoster virus reactivation due to COVID-19 or COVID-19 vaccine inoculation in older individuals with pre-existing conditions, this case report describes the first case of varicella-zoster virus reactivation on a healthy, young male in the absence of pre-existing conditions. The mechanisms underlying varicella-zoster virus reactivation in patients with COVID-19 are unknown and should be further characterized.
All Keywords
【저자키워드】 Pfizer-BioNTech, COVID-19 vaccinations, shingles, Varicella–zoster virus,
【저자키워드】 Pfizer-BioNTech, COVID-19 vaccinations, shingles, Varicella–zoster virus,